Your browser doesn't support javascript.
loading
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation.
Benetti, Elisa; Mastrocola, Raffaella; Vitarelli, Giovanna; Cutrin, Juan Carlos; Nigro, Debora; Chiazza, Fausto; Mayoux, Eric; Collino, Massimo; Fantozzi, Roberto.
Afiliação
  • Benetti E; Departments of Drug Science and Technology (E.B., G.V., F.C., M.C., R.F.), Clinical and Biological Sciences (R.M., D.N.), and Biotechnology and Sciences for the Health (J.C.C.), University of Turin, Turin, Italy; and Boehringer Ingelheim Pharma, Biberach an der Riss, Germany (E.M.) elisa.benetti@uni
  • Mastrocola R; Departments of Drug Science and Technology (E.B., G.V., F.C., M.C., R.F.), Clinical and Biological Sciences (R.M., D.N.), and Biotechnology and Sciences for the Health (J.C.C.), University of Turin, Turin, Italy; and Boehringer Ingelheim Pharma, Biberach an der Riss, Germany (E.M.).
  • Vitarelli G; Departments of Drug Science and Technology (E.B., G.V., F.C., M.C., R.F.), Clinical and Biological Sciences (R.M., D.N.), and Biotechnology and Sciences for the Health (J.C.C.), University of Turin, Turin, Italy; and Boehringer Ingelheim Pharma, Biberach an der Riss, Germany (E.M.).
  • Cutrin JC; Departments of Drug Science and Technology (E.B., G.V., F.C., M.C., R.F.), Clinical and Biological Sciences (R.M., D.N.), and Biotechnology and Sciences for the Health (J.C.C.), University of Turin, Turin, Italy; and Boehringer Ingelheim Pharma, Biberach an der Riss, Germany (E.M.).
  • Nigro D; Departments of Drug Science and Technology (E.B., G.V., F.C., M.C., R.F.), Clinical and Biological Sciences (R.M., D.N.), and Biotechnology and Sciences for the Health (J.C.C.), University of Turin, Turin, Italy; and Boehringer Ingelheim Pharma, Biberach an der Riss, Germany (E.M.).
  • Chiazza F; Departments of Drug Science and Technology (E.B., G.V., F.C., M.C., R.F.), Clinical and Biological Sciences (R.M., D.N.), and Biotechnology and Sciences for the Health (J.C.C.), University of Turin, Turin, Italy; and Boehringer Ingelheim Pharma, Biberach an der Riss, Germany (E.M.).
  • Mayoux E; Departments of Drug Science and Technology (E.B., G.V., F.C., M.C., R.F.), Clinical and Biological Sciences (R.M., D.N.), and Biotechnology and Sciences for the Health (J.C.C.), University of Turin, Turin, Italy; and Boehringer Ingelheim Pharma, Biberach an der Riss, Germany (E.M.).
  • Collino M; Departments of Drug Science and Technology (E.B., G.V., F.C., M.C., R.F.), Clinical and Biological Sciences (R.M., D.N.), and Biotechnology and Sciences for the Health (J.C.C.), University of Turin, Turin, Italy; and Boehringer Ingelheim Pharma, Biberach an der Riss, Germany (E.M.).
  • Fantozzi R; Departments of Drug Science and Technology (E.B., G.V., F.C., M.C., R.F.), Clinical and Biological Sciences (R.M., D.N.), and Biotechnology and Sciences for the Health (J.C.C.), University of Turin, Turin, Italy; and Boehringer Ingelheim Pharma, Biberach an der Riss, Germany (E.M.).
J Pharmacol Exp Ther ; 359(1): 45-53, 2016 10.
Article em En | MEDLINE | ID: mdl-27440421
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Dieta / Metabolismo dos Lipídeos / Inflamassomos / Glucosídeos Limite: Animals Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Dieta / Metabolismo dos Lipídeos / Inflamassomos / Glucosídeos Limite: Animals Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos